unknown
Stage
2017
Founded
1
Investors
About
A2A develops pharmaceuticals, focusing on clinical-stage drug candidates to treat respiratory and infectious diseases.
Explore A2A's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.